The COVID-19 Treatment Guidelines were developed to provide clinicians with guidance on caring for
patients with COVID-19. Because clinical information about the optimal management of COVID-19
is evolving quickly, these Guidelines are updated frequently to reflect newly published data and other
authorita...
This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neu...
Intra-articular injections are sometimes used to relieve pain for people with osteoarthritis. These include injections with corticosteroids, hyaluronan and stem cells. Corticosteroid injections are undertaken to deliver this high dose anti-inflammatory agent within the joint to reduce inflammation of the...
In 2021, the Executive Guideline Steering Group (GSG) for the World Health Organization (WHO) maternal and perinatal health recommendations prioritized updating the then current recommendations on the use of antenatal corticosteroids as published in the WHO recommendations on interventions to improve pre...
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...
Inhibidores de las Cinasas Janus/uso terapéutico,
COVID-19/tratamiento farmacológico,
Antivirales/uso terapéutico,
Ivermectina/uso terapéutico,
Hidroxicloroquina/uso terapéutico,
Plasma/inmunología,
Fluvoxamina/uso terapéutico,
Colchicina/uso terapéutico,
Inmunización Pasiva,
Receptores de Interleucina-6/uso terapéutico,
Lopinavir/uso terapéutico,
Corticoesteroides/uso terapéutico
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/tratamiento farmacológico,
Corticoesteroides/uso terapéutico,
Antivirales/uso terapéutico,
COVID-19/complicaciones,
Embolia Pulmonar/complicaciones,
Pulmón/patología,
Anticoagulantes/uso terapéutico,
Dabigatrán/uso terapéutico,
Heparina/uso terapéutico,
4-Hidroxicumarinas/uso terapéutico,
Aspirina/uso terapéutico
This guideline covers the care of women at increased risk of, or with symptoms and signs of, preterm labour (before 37 weeks), and women having a planned preterm birth. It aims to reduce the risks of preterm birth for the baby and describes treatments to prevent or delay early labour and birth.
In this ...
Primary immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia in children, with a reported incidence of 1.1-12.5 cases per 100 000 children. However, currently, there are several definitions of ITP, as well as diagnostic and therapeutic approaches. To develop an evidence-based clinic...
This guideline covers diagnosing and managing bronchiolitis in babies and children. It aims to help
healthcare professionals diagnose bronchiolitis and identify if babies and children should be cared
for at home or in hospital. It describes treatments and interventions that can be used to help with
the s...
Fernandez, Evans Perez;
Travis, William;
Lynch, David;
Brown, Kevin;
Johannson, Kerri;
Selman, Moises;
Ryu, Jay;
Wells, Athol;
Huang, Yuh-Chin;
Pereira, Carlos;
Scholand, Mary-Beth;
Villar, Ana;
Inase, Naohiko;
Evans, Richard;
Mette, Stephen;
Frazer-Green, Lindsy.
The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved panelists developed key questions regarding the diagnosis o...
